메뉴 건너뛰기




Volumn 102, Issue 4, 2009, Pages 688-693

Long-term complications of medical patients with hospital-acquired venous thromboembolism

Author keywords

Chronic thromboembolic pulmonary hypertension; Deep vein thrombosis; Medical patients; Postthrombotic syndrome; Prophylaxis; Pulmonary embolism; Surgical patients; Venous thromboembolism

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MORTALITY; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RECURRENT DISEASE; RISK FACTOR; THROMBOEMBOLISM; VENOUS THROMBOEMBOLISM;

EID: 70449485201     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-04-0266     Document Type: Article
Times cited : (67)

References (39)
  • 1
    • 38649115655 scopus 로고    scopus 로고
    • Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): A multinational cross-sectional study
    • Cohen AT, Tapson VF, Bergmann JF, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008; 371: 387-394.
    • (2008) Lancet , vol.371 , pp. 387-394
    • Cohen, A.T.1    Tapson, V.F.2    Bergmann, J.F.3
  • 2
    • 60249092118 scopus 로고    scopus 로고
    • U.S Department of Health and Human Services. Available at: Accessed February 10, 2009
    • U.S Department of Health and Human Services. Office of the Surgeon General. The Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. Available at: http://surgeongeneral.gov/topics/deepvein/ calltoaction/remarks-dvt.html. Accessed February 10, 2009.
    • The Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism
  • 5
    • 0038380256 scopus 로고    scopus 로고
    • The epidemiology of venous thromboembolism
    • White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107: I-4-I-8.
    • (2003) Circulation , vol.107
    • White, R.H.1
  • 6
    • 0342577769 scopus 로고    scopus 로고
    • Recurrent venous thromboembolism after deep vein thrombosis. Incidence and risk factors
    • Hansson PO, Sorbo J. Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis. Incidence and risk factors. Arch Intern Med 2000; 160: 769-774.
    • (2000) Arch Intern Med , vol.160 , pp. 769-774
    • Hansson, P.O.1    Sorbo, J.2    Eriksson, H.3
  • 7
    • 18444412628 scopus 로고    scopus 로고
    • Chronic venous insufficiency
    • Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation 2005; 111: 2398-2409.
    • (2005) Circulation , vol.111 , pp. 2398-2409
    • Eberhardt, R.T.1    Raffetto, J.D.2
  • 8
    • 0346688755 scopus 로고    scopus 로고
    • Relationship between Deep Venous Thrombosis and the Postthrombotic Syndrome
    • DOI 10.1001/archinte.164.1.17
    • Kahn SR, Ginsberg JS. Relationship between deep vein thrombosis and the postthrombotic syndrome. Arch Intern Med 2004; 164: 17-26. (Pubitemid 38067385)
    • (2004) Archives of Internal Medicine , vol.164 , Issue.1 , pp. 17-26
    • Kahn, S.R.1    Ginsberg, J.S.2
  • 9
    • 33646196216 scopus 로고    scopus 로고
    • Chronic thromboembolic pulmonary hypertension
    • Hoeper MM, Mayer E, Simonneau G, et al. Chronic thromboembolic pulmonary hypertension. Circulation 2006; 113: 2011-2020.
    • (2006) Circulation , vol.113 , pp. 2011-2020
    • Hoeper, M.M.1    Mayer, E.2    Simonneau, G.3
  • 10
  • 11
    • 4644288189 scopus 로고    scopus 로고
    • Prevention of venous thromboembolism
    • The Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy
    • Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism. The Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126: 338S-400S.
    • (2004) Chest , vol.126
    • Geerts, W.H.1    Pineo, G.F.2    Heit, J.A.3
  • 12
    • 84914708688 scopus 로고    scopus 로고
    • and Human Services. Available at: Accessed February 10, 2009
    • U.S Department of Health and Human Services. Overview of the Healthcare Cost and Utilization Project. Available at: http://www.hcup-us.ahrq.gov/over view.jsp. Accessed February 10, 2009.
    • Overview of the Healthcare Cost and Utilization Project
  • 14
    • 0023232649 scopus 로고
    • A cost-effectiveness analysis of prophylaxis against deep-vein thrombosis in major orthopedic surgery
    • DOI 10.1001/jama.257.2.203
    • Oster G, Tuden RL, Colditz GA. A cost-effectiveness analysis of prophylaxis against deep vein thrombosis in major orthopedic surgery. JAMA 1987; 257: 203-208. (Pubitemid 17207832)
    • (1987) Journal of the American Medical Association , vol.257 , Issue.2 , pp. 203-208
    • Oster, G.1    Tuden, R.L.2    Colditz, G.A.3
  • 15
    • 35048860791 scopus 로고    scopus 로고
    • The VTE Impact Assessment Group in Europe (VITAE)
    • Cohen AT, Agnelli G, Anderson FA, et al. The VTE Impact Assessment Group in Europe (VITAE). Thromb Haemost 2007; 98: 756-764.
    • (2007) Thromb Haemost , vol.98 , pp. 756-764
    • Cohen, A.T.1    Agnelli, G.2    Anderson, F.A.3
  • 16
    • 34447634273 scopus 로고    scopus 로고
    • Thromboprophylaxis rates in US medical centers: Success or failure?
    • Amin A, Stemkowski S, Lin J, at al. Thromboprophylaxis rates in US medical centers: success or failure? J Thromb Haemost 2007; 5: 16101-16116.
    • (2007) J Thromb Haemost , vol.5 , pp. 16101-16116
    • Amin, A.1    Stemkowski, S.2    Lin, J.3
  • 17
  • 18
    • 2342514219 scopus 로고    scopus 로고
    • Risk factors for venous thromboembolism in hospitalized patients with acute medical illness. Analysis of the MEDENOX study
    • Alikahan R, Cohen AT, Combe S, et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness. Analysis of the MEDENOX study. Arch Intern Med 2004; 164: 963-968.
    • (2004) Arch Intern Med , vol.164 , pp. 963-968
    • Alikahan, R.1    Cohen, A.T.2    Combe, S.3
  • 20
    • 34548674220 scopus 로고    scopus 로고
    • Venous thromboembolism in patients with active cancer
    • DOI 10.1160/TH07-04-0242
    • Seddighzadeh A, Shetty R, Goldhaber SZ. Venous thromboembolism in patients with active cancer. Thromb Haemost 2007; 98: 656-661. (Pubitemid 47412893)
    • (2007) Thrombosis and Haemostasis , vol.98 , Issue.3 , pp. 656-661
    • Seddighzadeh, A.1    Shetty, R.2    Goldhaber, S.Z.3
  • 21
    • 0015520956 scopus 로고
    • Low dose heparin after myocardial infarction
    • Handley, AJ. Low dose heparin after myocardial infarction. Lancet 1972; 2: 623-624.
    • (1972) Lancet , vol.2 , pp. 623-624
    • Handley, A.J.1
  • 22
    • 0015796571 scopus 로고
    • A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infraction
    • Warlow C, Beattie AG, Terry G, et al. A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infraction. Lancet 1973; 2: 934-936.
    • (1973) Lancet , vol.2 , pp. 934-936
    • Warlow, C.1    Beattie, A.G.2    Terry, G.3
  • 23
    • 0017341166 scopus 로고
    • Preventing thromboembolism after myocardial infarction: Effect of low dose heparin or smoking
    • Emerson PA, Marks P. Preventing thromboembolism after myocardial infraction: effect of low dose heparin or smoking. BMJ 1977; 1: 18-20. (Pubitemid 8016477)
    • (1977) British Medical Journal , vol.1 , Issue.6052 , pp. 18-20
    • Emerson, P.A.1    Marks, P.2
  • 24
    • 0037495140 scopus 로고    scopus 로고
    • Prevention of venous thromboembolism in medical patients with enoxaparin. A subgroup analysis of the Medenox study
    • Alikahan R, Cohen AT, Combe S, et al. Prevention of venous thromboembolism in medical patients with enoxaparin. A subgroup analysis of the Medenox study. Blood Coagul Fibrinolysis 2003; 14: 341-346.
    • (2003) Blood Coagul Fibrinolysis , vol.14 , pp. 341-346
    • Alikahan, R.1    Cohen, A.T.2    Combe, S.3
  • 25
    • 60849097273 scopus 로고    scopus 로고
    • Risk of venous thromboembolism with rheumatoid arthritis
    • Matta F, Singala R, Yaekoub AY, et al. Risk of venous thromboembolism with rheumatoid arthritis. Thromb Haemost 2009; 101: 134-138.
    • (2009) Thromb Haemost , vol.101 , pp. 134-138
    • Matta, F.1    Singala, R.2    Yaekoub, A.Y.3
  • 26
    • 34347237637 scopus 로고    scopus 로고
    • Thromboprophylaxis with dalteparin in medical patients: Which patients benefits?
    • Cohen AT, Turpie AGG, Leizorovicz A, et al. Thromboprophylaxis with dalteparin in medical patients: which patients benefits? Vasc Med 2007; 12: 123-128.
    • (2007) Vasc Med , vol.12 , pp. 123-128
    • Cohen, A.T.1    Turpie, A.G.G.2    Leizorovicz, A.3
  • 27
    • 0022453225 scopus 로고
    • Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke
    • McCarthy ST, Turner J. Low dose subcutaneous heparin in the prevention of deep vein thrombosis and pulmonary emboli following acute stroke. Age and Aging 1986; 15: 84-88. (Pubitemid 16079779)
    • (1986) Age and Ageing , vol.15 , Issue.2 , pp. 84-88
    • McCarthy, S.T.1    Turner, J.2
  • 28
    • 34247188553 scopus 로고    scopus 로고
    • The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): An open-label randomised comparison
    • DOI 10.1016/S0140-6736(07)60633-3, PII S0140673607606333
    • Sherman DG, Albers GW, Bladin C, et al. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischemic stroke (PREVAIL Study): an open-label randomized comparison. Lancet 2007; 369: 1347-1355. (Pubitemid 46621092)
    • (2007) Lancet , vol.369 , Issue.9570 , pp. 1347-1355
    • Sherman, D.G.1    Albers, G.W.2    Bladin, C.3    Fieschi, C.4    Gabbai, A.A.5    Kase, C.S.6    O'Riordan, W.7    Pineo, G.F.8
  • 29
    • 43949146626 scopus 로고    scopus 로고
    • Venous and arterial thrombosembolism in severe sepsis
    • Levine RL, LeClerc JR, Bailey JE, et al. Venous and arterial thrombosembolism in severe sepsis. Thromb Haemost 2008; 99: 892-898.
    • (2008) Thromb Haemost , vol.99 , pp. 892-898
    • Levine, R.L.1    Leclerc, J.R.2    Bailey, J.E.3
  • 31
    • 43949121402 scopus 로고    scopus 로고
    • Prevention of venous thromboembolism after acute spinal cord injury with low-dose heparin or low-molecular-weight heparin
    • DOI 10.1160/TH07-09-0540
    • Paciaroni M, Ageno W, Agnelli G. Prevention of thromboembolism after acute spinal injury with low-dose heparin or low-molecular-weight heparin. Thromb Haemost 2008; 99: 978-980. (Pubitemid 351705325)
    • (2008) Thrombosis and Haemostasis , vol.99 , Issue.5 , pp. 978-980
    • Paciaroni, M.1    Ageno, W.2    Agnelli, G.3
  • 33
    • 43749118513 scopus 로고    scopus 로고
    • Death due to recurrent thromboembolism among younger healthier individuals hospitalized for idiopathic pulmonary embolism
    • DOI 10.1160/TH07-09-0557
    • White RH, Zhou H, Murin S. Death due to recurrent thromboembolism among young healthier individuals hospitalized for idiopathic pulmonary embolism. Thromb Haemost 2008; 99: 683-690. (Pubitemid 351694224)
    • (2008) Thrombosis and Haemostasis , vol.99 , Issue.4 , pp. 683-690
    • White, R.H.1    Zhou, H.2    Murin, S.3
  • 35
    • 2442643903 scopus 로고    scopus 로고
    • Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism
    • For the Thromboembolic Pulmonary Hypertension Study Group
    • Pengo V, Lensing AWA, Prins MH, et al. For the Thromboembolic Pulmonary Hypertension Study Group. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004; 350: 2257-2264.
    • (2004) N Engl J Med , vol.350 , pp. 2257-2264
    • Pengo, V.1    Lensing, A.W.A.2    Prins, M.H.3
  • 36
    • 3242733185 scopus 로고    scopus 로고
    • A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism. Use in patients undergoing major orthopedic surgery
    • Sullivan SD, Davidson BL, Kahn SR, et al. A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism. Use in patients undergoing major orthopedic surgery. Pharmacoeconomics 2004; 22: 605-620.
    • (2004) Pharmacoeconomics , vol.22 , pp. 605-620
    • Sullivan, S.D.1    Davidson, B.L.2    Kahn, S.R.3
  • 37
    • 34548009133 scopus 로고    scopus 로고
    • Double trouble for 2,609 hospitalized medical patients who developed deep vein thrombosis: Prophylaxis omitted more often and pulmonary embolism more frequent
    • DOI 10.1378/chest.07-0430
    • Piazza G, Seddighzadeh A, Goldhaber SZ. Double trouble for 2,609 hospitalized medical patients who develop deep vein thrombosis; prophylaxis omitted more often and pulmonary embolism more frequent. Chest 2007; 132: 554-561. (Pubitemid 47282388)
    • (2007) Chest , vol.132 , Issue.2 , pp. 554-561
    • Piazza, G.1    Seddighzadeh, A.2    Goldhaber, S.Z.3
  • 38
    • 33750569372 scopus 로고    scopus 로고
    • Economic burden of deep vein thrombosis, pulmonary embolism, and post-thrombotic syndrome
    • MacDougall DA, Feliu AL, Boccuzzi SJ, et al. Economic burden of deep vein thrombosis, pulmonary embolism, and post-thrombotic syndrome. Am J Health-Syst Pharm 2006; 63 (Suppl 6): S5-15.
    • (2006) Am J Health-Syst Pharm , vol.63 , Issue.SUPPL. 6
    • MacDougall, D.A.1    Feliu, A.L.2    Boccuzzi, S.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.